Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

Study shows chemotherapy and radiotherapy are safe for babies in utero

Prof Frederic Amant - University Hospital Leuven
Study shows chemotherapy and radiotherapy are safe for babies in utero ( Prof Frederic Amant - University Hospital Leuven )
27 Sep 2014

Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy

Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa
Rolapitant reduces nausea and vomiting associated with cisplatin-based chemotherapy ( Dr Bernardo Leon Rapoport - The Medical Oncology Centre, Johannesburg, South Africa )
27 Sep 2014

New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia

Prof David Currow - Flinders University, Adelaide, Australia
New drug anamorelin shows improvement in appetite and body mass in non-small cell lung cancer with cancer anorexia-cachexia ( Prof David Currow - Flinders University, Adelaide, Australia )
27 Sep 2014

Second-line afatinib significantly improves PFS in metastatic head and neck cancer

Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium
Second-line afatinib significantly improves PFS in metastatic head and neck cancer ( Dr Jean-Pascal Machiels - Cliniques Universitaires Saint-Luc, Brussels, Belgium )
27 Sep 2014

Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction

Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA
Optimising metastic renal cell carcinoma (mRCC): Treatment lessons from the real world: Introduction ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )
23 Sep 2014

Additional treatment options impact first-line treatment of mRCC: No

Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France
Additional treatment options impact first-line treatment of mRCC: No ( Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, Paris, France )
23 Sep 2014

Current treatment options in mRCC

Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA
Current treatment options in mRCC ( Dr Thomas Hutson - Baylor University Medical Center, Dallas, USA )
23 Sep 2014

Discussion: Additional treatment options impact first-line treatment of mRCC

Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
Discussion: Additional treatment options impact first-line treatment of mRCC ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014

Additional treatment options impact first-line treatment of mRCC: Yes

Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium
Additional treatment options impact first-line treatment of mRCC: Yes ( Prof Patrick Schöffski - University Hospitals Leuven, Leuven, Belgium )
23 Sep 2014

What have we learned? Expert perspectives

Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán
What have we learned? Expert perspectives ( Dr Thomas Hutson; Prof Stéphan Oudard; Prof Patrick Schöffski; Dr Ignacio Durán )
23 Sep 2014

From clinical trial to clinical practice: Evidence from the real world

Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain
From clinical trial to clinical practice: Evidence from the real world ( Dr Ignacio Durán - Associate Director of Clinical Research at START Madrid, Madrid, Spain )
23 Sep 2014

IEO to have a new Scientific Director at the end of the year when Prof Umberto Veronesi hands over the role to Prof Roberto Orecchia

Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy
IEO to have a new Scientific Director at the end of the year when Prof Umberto Veronesi hands over the role to Prof Roberto Orecchia ( Prof Gordon McVie - ecancer and European Institute of Oncology, Milan, Italy )
23 Sep 2014